AKT1 and nasopharyngeal carcinoma: Taken together, these data suggest that ET-1 activates the PI3K/AKT/mTOR and MAPK/ERK1/2 signaling pathways via ETAR and then upregulates CXCR4 expression in 6-10B NPC cells.